LDEye Outpatient is an integrated solution for Non Alcoholic Fatty Liver Disease (NAFLD) patients consisting of:
1. A smart mobile application for coaching and monitoring patients' diet and exercise during their daily activities at home
2. A cloud-based web platform for the management of patients by doctors and dietitians with the capability of direct communication and the storage/analysis of data
Over 3x energy saved vs standard wireless IoT sensor implementations
Using smartphone technology to assess cardiac health
The novel technology uses voltage-based method to differentiate cancerous from non-cancerous tissue and can detect a wide range of cancerous tissue in real-time.
A robotic optical-biopsy scanning framework termed EndoDrone is proposed to improve the sensitivity of gastrointestinal (GI) endoscopy by automated scanning and real-time classification of wide tissue areas based on optical data. A “hot-spot” map is generated to highlight dysplastic or cancerous lesions for further scrutiny or concurrent resection. The device works as an add-on accessory to any conventional endoscope and to our knowledge is the first of its kind. The current functional prototype, which uses hyperspectral (HS) optical biopsy, is compatible with the anatomical dimensions of the colon, is envisaged to allow the identification of flat and small precancerous lesions that are currently missed.
Patient Metabolic profiling for personalised medicine.
Gene expression for tuberculosis diagnosis
Lactobacillus ST peptide for therapeutic use against inflammatory bowel disease
A novel surgical clip and applicator that allows large-area clamping of surgical anatomy for use in minimally invasive surgery, with the ability to rotate within the body.
Dr Mark Isalan – Reader in Gene Network Engineering at Imperial College London – and collaborators have developed a novel gene therapy for Huntington’s Disease that leverages zinc finger protein technology.